Abstract. Although sleep-disordered breathing and cognitive impairment are common features of patients with myotonic dystrophy type 1 (DM1), little is known about their relationship. Forty-three adult DM1 patients underwent 2 sequential polysomnographic sessions and a neuropsychological test battery (intellectual functioning, attention, language, memory, and executive functions). Lower scores in attention, vigilance, and executive functioning tests were associated with higher number of apneic/hypopneic episodes per hour of sleep and longer total sleep time at an oxyhemoglobin saturation of less than 90%. Results suggest a potential role for nighttime breathing problems in the cognitive impairment often observed in DM1 patients.
INTRODUCTION
Cognitive alterations have been largely described in patients with myotonic dystrophy type 1 (DM1). In the adult phenotype, the neuropsychological profile is characterized by deficits in the domain of higher cognitive functions. More particularly, concentration and attention problems, impairments in visuo-spatial and visuo-constructive skills, and perseveration and rigidity in cognitive tasks were reported [1] [2] [3] . While some studies noted a link between CNS alterations and neuropsychological data [4] , others did not [5] . * Correspondence to: B. Gallais, Groupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), 2230 rue de l'Hôpital, G7X 7X2 Jonquière, QC, Canada. E-mail: B.Gallais@ Usherbrooke.ca.
Sleep-disordered breathing (SDB), hypercapnia and nocturnal oxygen desaturation have also been consistently reported in DM1. During sleep, patients with DM1 may namely develop apneas and hypopneas of the central, obstructive, or mixed types [6] . The associated sleep disruption may yield diminished neurocognitive performance. For example, a relationship between an elevated sleep apnea index and such cognitive impairments as decrements in attention/vigilance, executive functions, language, memory, and psychomotor speed has been reported [7] [8] [9] . Yet, only two studies have evaluated the relationship between cognitive function and sleep-related breathing disturbances in DM1 [10, 11] . Results indicated no significant relationship between the degree of cognitive deficit and sleep fragmentation or respiratory problems at night but these studies may have been limited by their relatively small sample sizes (respectively n = 8 and n = 23).
The main objective of the present study is to reappraise the relationship between the severity of SDB and the nature and extent of cognitive deficits in a larger sample of patients with classical and late onset phenotypes of DM1. A secondary objective is to explore the effect of SDB on the extent of cognitive deficits.
METHODS

Participants
Forty-three adult patients (29 females; M (age) ± SD = 49 ± 10 years) with a molecular diagnosis of DM1 were selected without regards to daytime/nocturnal sleep complaints. All patients were registered at a university affiliated neuromuscular clinic (Saguenay, Québec). Patients with congenital or childhood forms of DM1 were excluded. Information was gathered regarding age, sex, disease duration, and body mass index (BMI). CTG repeat was determined using Southern blot analysis. Muscular impairment was assessed using the Muscular Impairment Rating Scale (MIRS). Ethical approval and informed consent were obtained. More details of the study design and protocol have been published elsewhere [12] .
Neuropsychological assessment
All participants underwent neuropsychological testing at home, including intellectual functioning (WAIS-R 7 subtests form), perceptual functions 
Sleep assessment
Participants underwent two sequential polysomnographic sessions in the sleep unit of an academic hospital. Only data from the second night are presented herein. Apnea-hypopnea index (AHI) was defined as the average number of apneic/hypopneic episodes per hour of sleep, and SaO 2 90%, as the percentage of sleep time with oxyhemoglobin saturation below 90%.
Daytime sleepiness and fatigue
Participants were asked to rate their level of sleepiness and fatigue with the Daytime Sleepiness Scale (DSS), the Epworth Sleepiness Scale (ESS) and the Krupp Fatigue Severity Scale (FSS).
Statistical analysis
Pearson's or Spearman's correlations were performed according to data normality using SPSS (version 18.0). A series of hierarchical multiple regression analyses were conducted to determine whether SDB parameters (AHI and SaO 2 90%) can increase the proportion of variance accounted for cognitive test scores, after that other potential explanatory or independent variables are entered: age, nCTG, MIRS, disease duration, BMI, fatigue, and daytime sleepiness. Preliminary analyses were conducted to ensure that there was no violation of the assumptions of normality, linearity, multicollinearity, and homoscedasticity. Collinearity was examined with a matrix of correlations, using the Spearman rank correlation coefficient between independent variables, with an r > 0.7 in at least 1 correlation as the criterion for multicollinearity. For each regression model, only independent variables that correlated at p > 0.25 with the dependent variable (neuropsychological test score) were entered in Block 1 (Table 1) . Since AHI and SaO 2 90% were strongly correlated (p = 0.603), they were entered separately in each regression model (Block 2).
RESULTS
Regarding scores on the MIRS, participants' muscular impairment was categorized as mild (n = 7), moderate (n = 6), or severe (n = 30). Mean (±SD) BMI, AHI, SaO 2, and CTGn were respectively 28.7 (±6.6) kg/m 2 , 21.8 (±14.4) per hour of sleep, 18.2 (±29.9) % and 839.8 (±580.4). Apneas and hypopneas were of the obstructive type in 87% of events. AHI was categorized as normal (AHI <5; n = 6, 14%), mild (AHI = 5-15; n = 10, 23.3%), moderate (AHI = 15-30; n = 15, 34.9%) and severe (AHI >30; n = 12, 27.9%). SaO 2 was categorized as normal (SaO 2 ≥95% per hour of sleep; n = 9, 20.9%), mild decrease (90%<SaO 2 <95%; n = 16, 37.2%) and severe decrease (SaO 2 ≤90%; n = 18, 41.9%). Weight was categorized as normal (BMI ≤25; n = 12, 27.9%), overweight (25 (Table 2) . Hierarchical multiple regression analyses were then conducted to assess the ability of AHI and SaO 2 90% to separately predict levels of Stroop color word, Ruff 2 & 7 total speed and total accuracy, RCFT-Recognition, and WAIS-R block design scores, after controlling for the influence of additional potential explanatory variables. Results showed that after controlling for nCTG, MIRS and disease duration, AHI explained an additional 11% of the variance of the Stroop color word task scores (R 2 = 0.41; Adjusted R 2 = 0.34; p < 0.05); and that after controlling for nCTG and disease duration, SaO 2 90% explained an additional 7% (R 2 = 0.50; Adjusted R 2 = 0.45; p < 0.05) and AHI explained an additional 6% (R 2 = 0.49; Adjusted R 2 = 0.44; p = 0.058) of the variance of the Ruff 2 & 7 total speed scores ( Table 1) .
DISCUSSION
These findings suggest a role for respiratory problems at night in the cognitive impairment often reported in DM1. More particularly, after controlling for disease severity variables, sleep apnea severity explained partially the variance in executive functioning and tended to explain the variance in attention speed abilities in patients with DM1, which is consistent with previous findings in other conditions [13] . In addition, oxygen desaturation partially explained the variance in attention speed abilities. A wide range of potential mechanisms have been advanced to explain how sleep apnea may negatively impact upon cognitive function, namely after brain injury [14] . Considering these results, SDB may be involved in the fronto-subcortical modifications (anatomical or functional) explaining decreased psychomotor speed and executive dysfunction in DM1. Future studies using functional neuroimaging techniques in combination with neuropsychological testing comparing DM1 patients with and without SDB, may be useful to further document this association.
Moreover, the strong relationship between BMI and AHI observed herein is in agreement with data obtained from general population studies [15] . Given the prevalence of obesity in DM1 [16] and its link to both AHI and SaO 2 in the general population, weight reduction program could be an important treatment strategy to help reduce AHI in DM1 patients [17] , and ultimately, have an indirect positive impact on cognitive functioning. In addition, CPAP treatment in patients with severe obstructive sleep apnea was recently shown to result in mild, transient improvement in measures of executive functioning [18] . These latter findings should be replicated in DM1 patients. 
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